Domain Surgical

About:

Domain Surgical creates energy-based surgical products for precise soft tissue cutting and coagulation.

Website: http://domainsurgical.com

Twitter/X: DomainSurgical

Top Investors: OrbiMed, BioStar Capital

Description:

Domain Surgical is a medical device company that is creating energy-based surgical products for precise soft tissue cutting and coagulation. It creates energy-based equipment used in specialty surgical procedures. Its patent-pending technology produces surface-only tissue effects with energy that does not pass through the patient designed with the surgical staff in mind, for simple user-interface and training. The company manufactures and markets the FMwand Ferromagnetic Surgical System, a hemostatic dissection device that uses pure thermal energy to cut and coagulate soft tissue, without passing an electrical current through the patient. The FMwand imparts as little as 1/10th the amount of thermal injury compared to traditional electrosurgery devices. The FMwand provides fine dissection with a layer-by-layer precision that is unmatched by existing surgical technology.

Total Funding Amount:

$49.6M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Salt Lake City, Utah, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)domainsurgical.com

Founders:

David J. McNally, David McNally

Number of Employees:

1-10

Last Funding Date:

2014-03-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai